Technical Analysis for MYOV - Myovant Sciences Ltd.

Grade Last Price % Change Price Change
grade D 15.28 -4.20% -0.67
MYOV closed down 4.2 percent on Tuesday, October 20, 2020, on 75 percent of normal volume.
Earnings due: Nov 9
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical MYOV trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
20 DMA Resistance Bearish -4.20%
Bearish Engulfing Bearish -4.20%
Wide Bands Range Expansion -4.20%
Wide Bands Range Expansion -7.84%
MACD Bullish Signal Line Cross Bullish -5.80%
Wide Bands Range Expansion -5.80%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -4.08%
Wide Bands Range Expansion -4.08%
Wide Bands Range Expansion -5.91%
Older End-of-Day Gignals for MYOV ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 7 hours ago
60 Minute Opening Range Breakdown about 9 hours ago
Down 3% about 9 hours ago
Down 2 % about 9 hours ago
Fell Below 10 DMA about 9 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health diseases and other endocrine-related disorders. Its lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist, for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The company also intends to develop RVT-602, an oligopeptide kisspeptin analog, for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. was founded in 2016 and is based in Hamilton, Bermuda. Myovant Sciences Ltd. operates as a subsidiary of Roivant Sciences Ltd.
Chemistry Biopharmaceutical Pain Prostate Cancer Endocrine System Hormones Amines Gnrh Antagonists Pyrimidines Uterine Fibroids Gonadotropin Releasing Hormone Antagonist Roivant Sciences Uterine Fibroid

Is MYOV a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 23.04
52 Week Low 4.15
Average Volume 1,300,692
200-Day Moving Average 14.57
50-Day Moving Average 18.39
20-Day Moving Average 16.35
10-Day Moving Average 15.72
Average True Range 1.19
ADX 22.87
+DI 21.33
-DI 32.59
Chandelier Exit (Long, 3 ATRs ) 19.48
Chandelier Exit (Short, 3 ATRs ) 16.98
Upper Bollinger Band 21.08
Lower Bollinger Band 11.63
Percent B (%b) 0.39
BandWidth 57.77
MACD Line -0.88
MACD Signal Line -0.98
MACD Histogram 0.0968
Fundamentals Value
Market Cap 1.38 Billion
Num Shares 90.1 Million
EPS -3.98
Price-to-Earnings (P/E) Ratio -3.84
Price-to-Sales 41.17
Price-to-Book 70.01
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.08
Resistance 3 (R3) 17.20 16.71 16.78
Resistance 2 (R2) 16.71 16.25 16.66 16.68
Resistance 1 (R1) 16.00 15.97 15.76 15.88 16.58
Pivot Point 15.51 15.51 15.39 15.46 15.51
Support 1 (S1) 14.80 15.05 14.56 14.68 13.98
Support 2 (S2) 14.31 14.77 14.26 13.88
Support 3 (S3) 13.60 14.31 13.78
Support 4 (S4) 13.48